A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis
Status:
Completed
Trial end date:
2019-05-07
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants
with nonradiographic axial spondyloarthritis (nonrad-axSpA).